MaxCyte, Inc. (LSE-MXCT) Stock Price Today • Wrapstocks

$3.27

24H

2.87%

Market Cap

3.6 M

Volume

195 K

Supply

1.1 M

Price Chart

About MaxCyte, Inc. - MXCT.L

MaxCyte, Inc. is a global clinical-stage company focused on cell-based medicines and life sciences that provides cell engineering technology to pharmaceutical and biotechnology organizations. They offer tools and services for drug discovery, drug development, and cell therapy, including their proprietary flow electroporation technology which enables the engineering of a wide range of cells.

MaxCyte, Inc. is committed to driving the acceleration of the discovery, development, manufacturing, and commercialization of next-generation, cell-based medicines. Their mission is centered on enabling their partners to advance their products to the clinic and the market faster and with greater success by providing efficient and streamlined cell engineering solutions.

MaxCyte, Inc. was founded by Douglas Doerfler in 1998.

As of the latest available information before any recent updates, MaxCyte, Inc. was led by Doug Doerfler, who is the founder, President, and Chief Executive Officer of the company.

MaxCyte, Inc. is headquartered in Gaithersburg, Maryland, USA, which is also its base country.

MaxCyte, Inc. is traded on the Nasdaq stock exchange under the ticker symbol MXCT.

MaxCyte, Inc. (MXCT) Price Live Data

The live price of MaxCyte, Inc. (MXCT) is $3.27, with a trading volume of 195,000 in the last 24 hours. Wrapstocks updates the MXCT price in real-time. MaxCyte, Inc. is down -2.87% in the last 24 hours. The company has a live market cap of $3,555,968.51 and a supply of 1,085,960 MXCT stocks.

MaxCyte, Inc. (MXCT) is traded on London Stock Exchange, and currently, the market is closed; trading will be resumed in 18 hours and 48 minutes.

LSE

London Stock Exchange